Abstract
Objective To investigate if wearing a cloth facemask could affect physiological and perceptual responses to exercise at distinct exercise intensities in healthy young individuals.
Methods In a crossover design, 9 participants (sex, female/male: 6/3; age: 13±1 years; BMI: 18.4±2.1 kg/m2; sexual maturity rating, I/II/III/IV: 0/3/4/2; VO2peak: 44.5±5.5 mL/kg/min) underwent a progressive square-wave test at four intensities: (1) at 80% of the ventilatory anaerobic threshold (VAT), (2) at VAT, and (3) at 40% between the VAT and V□O2peak wearing a triple-layered cloth facemask or not. These stages represented moderate, heavy, and very heavy domains and corresponded to 46±8%, 57±10% and 87±8% of V□O2peak. Participants then completed a final stage (severe) to exhaustion at a running speed equivalent to the maximum achieved during the cardio-respiratory exercise test (Peak). Physiological, metabolic, and perceptual measures were analysed.
Results Mask did not affect spirometry (forced vital capacity [FVC], peak expiratory flow [PEF1], forced expiratory volume [FEV]; all p > 0.27; Figure 1), respiratory (inspiratory capacity [IC], end-expiratory volume to functional vital capacity ratio [EELV/FVC], EELV, respiratory frequency [Rf], tidal volume [VT], Rf/VT, end-tidal carbo dioxide pressure [PetCO2], ventilatory equivalent and carbon dioxide ratio [VE/VCO2]; all p > 0.196), hemodynamic (heart rate [HR], systolic and diastolic blood pressure [SBP; DBP]; all p > 0.41), rated perceived exertion (RPE; p = 0.04) or metabolic measures (lactate; p = 0.78 Figure 2) at rest or at any exercise intensity. In both conditions, the same number of children (4 out of 9) were unable to finish the Peak stage, whereas one child did not complete exercise at the heavy domain while wearing no mask.
Conclusions This study shows that performing moderate to severe activity is safe and tolerable for healthy youth while wearing a cloth facemask. ClinicalTrials.gov: NCT04887714
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04887714
Funding Statement
The authors received no specific funding for this work. B.G (2017/13552-2), G.B. (2020/12036-3), G.P.E. (2020/07860-9), T.N.O. (2020/04368-6) and B.S. (2016/50438-0) have been financially supported by FAPESP. B.S. has also received a grant from Faculdade de Medicina da Universidade de Sao Paulo (2020.1.362.5.2).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol was approved by the ethics committee of the Hospital das Clinicas of the Faculty of Medicine of the University of Sao Paulo under the protocol 38569420.0.0000.0068
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
